INCI · — · CIR review pending · used in 15 products
팔미토일테트라펩타이드-7
PALMITOYL TETRAPEPTIDE-7
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.